10-K: Charlies Holdings, Inc. Reports Full Year 2023 Results Amidst Regulatory and Financial Challenges

Charlies Holdings, Inc. reports a decrease in revenue for 2023, alongside ongoing regulatory hurdles and concerns about its ability to continue as a going concern.

Summary

• Charlies Holdings, Inc. reported a net revenue of approximately $16.3 million for the year ended December 31, 2023, a decrease from $26.4 million in 2022.
• The company experienced a net loss of $2.093 million in 2023, compared to a net loss of $1.592 million in 2022.
• Operating activities used approximately $0.8 million in cash during 2023, compared to $1.7 million in 2022.
• The company's working capital was approximately $0.3 million as of December 31, 2023.
• The company has substantial doubt about its ability to continue as a going concern due to regulatory risks, industry challenges, and a low working capital position.
• The company launched a new product line, SPREE BAR, which it believes is not subject to FDA review, and hopes will be a major commercial opportunity.
• The company is focusing on expanding its sales team and international market presence to drive future growth.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with declining revenue, increasing losses, and substantial doubt about the company's ability to continue as a going concern. While there are some positive developments, such as the launch of a new product line, the overall tone is negative due to the significant financial and regulatory challenges.

Positives

• The company launched a new product line, SPREE BAR, which it believes is not subject to FDA regulation.
• The company is expanding its sales team and international market presence.
• The company has reduced operating expenses, including non-commission wages and benefits, merchant processing fees, and bad debt expense.

Negatives

• The company experienced a significant decrease in revenue, down 38.5% year-over-year.
• The company's net loss increased to $2.093 million in 2023.
• The company has substantial doubt about its ability to continue as a going concern.
• The company faces ongoing regulatory challenges, including the need for FDA approval for certain products.
• The company's working capital position has decreased to $0.3 million.

Risks

• The company faces significant regulatory risks, including potential FDA denials of product applications.
• The company's ability to continue as a going concern is uncertain due to financial and regulatory challenges.
• The company's products face intense competition and changes in consumer preferences.
• The company relies on third-party contract manufacturers, which could lead to supply chain issues.
• The company is subject to cyber-security risks that could disrupt operations.
• The company's business is subject to international risks and uncertainties.
• The company's products contain nicotine, which is considered to be a highly addictive substance.
• The company's products may not meet health and safety standards or could become contaminated.
• The company faces product liability risks that could expose it to significant insurance and loss expense.
• The company's success depends on its ability to create and expand brand awareness.
• The company's products may contain trace amounts of THC, which could lead to adverse consequences.
• The company's success depends on its ability to develop and introduce new products.
• The company faces competition from the illicit cannabis market.
• The company may not be able to adequately protect its intellectual property.
• The company's securities could be subject to wide fluctuations and your investment could decline in value.
• The company's common stock may be classified as penny stock, which could limit trading.
• The company has issued preferred stock with rights senior to its common stock.
• The company's bylaws designate courts within the state of Nevada as the sole and exclusive forum for certain types of actions and proceedings.
• You may not be able to hold the company's securities in your regular brokerage account.
• You should not rely on an investment in the company's common stock for the payment of cash dividends.

Future Outlook

The company plans to focus on the SPREE BAR product line, expand its sales team, and grow its international market share. The company also plans to develop intellectual property around technologies designed to prevent youth access to nicotine vapor products.

Management Comments

• Management has targeted opportunities for growth and has adopted an operational plan.
• Management believes that the transition to the SPREE BAR product line will give Charlie's an extraordinary opportunity to capture significant sales and market share in the vapor products marketplace in 2024 and beyond.
• Management believes that the company is well positioned to increase sales in countries where it already has a presence and in additional overseas markets.

Industry Context

The company operates in a highly competitive and rapidly evolving industry, facing competition from both established players and new entrants. The industry is also subject to significant regulatory scrutiny, particularly regarding flavored e-cigarettes and nicotine products. The company's focus on alternative alkaloid products and international expansion reflects an attempt to navigate these challenges.

Comparison to Industry Standards

• The company's revenue decline of 38.5% is significant and indicates a struggle to maintain market share in a competitive environment. Competitors such as Coastal Clouds, Juice Head, Elf Bar, Flum, Lost Mary, Geek Bar, and Raz are mentioned as identifiable competitors.
• The company's net loss of $2.093 million is a concern, especially when compared to the previous year's loss of $1.592 million. This indicates a need for improved cost management and revenue generation.
• The company's reliance on contract manufacturers is common in the industry, but it also exposes the company to supply chain risks. Competitors with better control of their supply and distribution may have an advantage.
• The company's focus on international expansion is a strategy used by many companies in the industry to diversify their revenue streams and mitigate regulatory risks in specific markets. However, this also introduces new challenges related to international regulations and market dynamics.
• The company's development of age-gating technology is a response to regulatory concerns about youth access to vapor products, which is a common issue in the industry. JUUL Labs is mentioned as a competitor also working on similar technology.

Management Changes

Related Party Transactions

• The company entered into a commercial lease for its corporate headquarters with Brandon Stump, Ryan Stump, and Keith Stump.
• The company entered into a loan agreement with Ryan Stump.
• The company issued unsecured promissory notes to several of its executives and employees, including Ryan Stump and Henry Sicignano III.

Stakeholder Impact

• Shareholders face the risk of losing some or all of their investment due to the company's financial challenges and going concern uncertainty.
• Employees may be affected by potential cost-cutting measures and the company's uncertain future.
• Customers may be impacted by potential changes in product availability and pricing.
• Suppliers may face increased risk due to the company's financial instability.
• Creditors face increased risk of non-payment due to the company's financial challenges.

Next Steps

• The company will focus on the SPREE BAR product line.
• The company will expand its sales team.
• The company will grow its international market share.
• The company will develop intellectual property around technologies designed to prevent youth access to nicotine vapor products.

Key Dates

Keywords

vape products, nicotine, hemp-derived products, FDA regulation, financial results, SPREE BAR, PMTA, going concern, revenue, net loss, operating expenses, working capital, international expansion, contract manufacturing, cybersecurity, intellectual property, stock dilution